Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 (@szusmani) 's Twitter Profile
Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰

@szusmani

Chief of Myeloma @MSKCancerCenter | Chair @ALLIANCE_org #mmsm Com | MD ≠ Provider| @ASH_hematology @ASTCT @ASCO |married to @ZainabShd | #BMTsm #CARTsm #CureMM

ID: 83911786

linkhttps://www.mskcc.org/cancer-care/doctors/saad-usmani calendar_today20-10-2009 19:46:12

13,13K Tweet

11,11K Takipçi

635 Takip Edilen

International Myeloma Foundation (@imfmyeloma) 's Twitter Profile Photo

Why Iceland? The IMF-supported iStopMM (Iceland Screens, Treats, or Prevents Multiple Myeloma) is the first large-scale screening study in the field, screening 80,000+ for precursors of MM in a bold effort to understand what causes it. #kNOwMyeloma

Myeloma Society (@myeloma_society) 's Twitter Profile Photo

🚨Attention IMS 2024 participants: Please download Bluesky to stay informed with the latest event updates. Follow us here ➡️bsky.app/profile/myelom….

🚨Attention IMS 2024 participants: Please download Bluesky to stay informed with the latest event updates. Follow us here ➡️bsky.app/profile/myelom….
Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 (@szusmani) 's Twitter Profile Photo

Join us for the Inaugural Kyle-Barlogie Memorial Sloan Kettering-Mayo Clinic Plasma Cell Disorders Symposium on November 22-23, 2024! This event isapproved for AMA PRA Category 1 Credits™️   Register by October 25th for the early bird discount! We look forward to seeing you

Join us for the Inaugural Kyle-Barlogie Memorial Sloan Kettering-Mayo Clinic Plasma Cell Disorders Symposium on November 22-23, 2024! This event isapproved for AMA PRA Category 1 Credits™️   
Register by October 25th for the early bird discount! We look forward to seeing you
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

Congrats Krina!! One of the most amazing and also kindest mentors we have in the #MMsm field! And both you and Robert Z. Orlowski have the best humor on early-morning calls… def need more of that especially when <8am PDT 🤣

Mehdi Hamadani, MD (@medihumdani) 's Twitter Profile Photo

At the Hill for ASTCT #ASTCTHillDay advocating for Accelerating Kid's access to Care Act (HR4758), ABC (caregiver) Act (HR8018) & NIH funding. Thank you Amy Klobuchar's team for supporting. #Minneasota

At the Hill for <a href="/ASTCT/">ASTCT</a> #ASTCTHillDay advocating for Accelerating Kid's access to Care Act (HR4758), ABC (caregiver) Act (HR8018) &amp; <a href="/NIH/">NIH</a> funding. Thank you <a href="/amyklobuchar/">Amy Klobuchar</a>'s team for supporting. #Minneasota
MSK Department of Medicine (@msk_deptofmed) 's Twitter Profile Photo

Save the date for the inaugural Plasma Cell Disorders Symposium that will take place from November 22 to 23 in person in NYC. CME credits are available. Learn more and register here: cvent.me/45zlnd Mayo Clinic Memorial Sloan Kettering Cancer Center #mmsm Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰

Save the date for the inaugural Plasma Cell Disorders Symposium that will take place from November 22 to 23 in person in NYC. CME credits are available. Learn more and register here: cvent.me/45zlnd 
<a href="/MayoClinic/">Mayo Clinic</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> #mmsm <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a>
Muzaffar Qazilbash (@transplant_doc) 's Twitter Profile Photo

Clinical outcomes with ide-cel in older patients (also frail) with RRMM. N=75, age >/=65. No difference in ORR, PFS or OS compared to younger patients #bmtsm #mmsm Krina Patel Leyla Shune MD ashpublications.org/bloodadvances/…

Clinical outcomes with ide-cel in older patients (also frail) with RRMM. N=75, age &gt;/=65. No difference in ORR, PFS or OS compared to younger patients #bmtsm #mmsm <a href="/DrKrinaPatel/">Krina Patel</a> <a href="/leshune/">Leyla Shune MD</a>
ashpublications.org/bloodadvances/…
Hamza Hashmi (@hhashmi87) 's Twitter Profile Photo

Tune into this great Onco-Nephrology Symposium at Memorial Sloan Kettering Cancer Center in #NYC with a stellar line up of speakers Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 I will talking on CAR T in RRMM & renal disease #MSKNephCME #MSKCME #MMSM #CART #MedTwitter #MedOncTwitter #kidney #cancer #MedEd

Tune into this great Onco-Nephrology Symposium at <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> in #NYC with a stellar line up of speakers <a href="/szusmani/">Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰</a> I will talking on CAR T in RRMM &amp; renal disease #MSKNephCME #MSKCME #MMSM #CART #MedTwitter #MedOncTwitter #kidney #cancer #MedEd
Alliance for Clinical Trials in Oncology (@alliance_org) 's Twitter Profile Photo

For #TrialTuesday, Dr.MHB Dana-Farber leads a new trial Alliance for Clinical Trials in Oncology A062101 to test the combination of two approved drugs & one experimental drug in pts w/relapsed or refractory #multiplemyeloma. Visit bit.ly/Alliance-A0621… #NCI #NCTN Multiple Myeloma RF @IMFMyeloma #MMSM Myeloma Chat Multiple Myeloma Hub

For #TrialTuesday, <a href="/DrMHB1/">Dr.MHB</a> <a href="/DanaFarber/">Dana-Farber</a> leads a new trial <a href="/ALLIANCE_org/">Alliance for Clinical Trials in Oncology</a> A062101 to test the combination of two approved drugs &amp; one experimental drug in pts w/relapsed or refractory #multiplemyeloma. Visit bit.ly/Alliance-A0621… #NCI #NCTN <a href="/theMMRF/">Multiple Myeloma RF</a> @IMFMyeloma <a href="/MMSMChats/">#MMSM Myeloma Chat</a> <a href="/MM_Hub/">Multiple Myeloma Hub</a>